Inter-alpha-trypsin inhibitor heavy chain H3 is a potential biomarker for disease activity in myasthenia gravis
Schroeter, CB; Nelke, C; Stascheit, F; Huntemann, N; Preusse, C; Dobelmann, V; Theissen, L; Pawlitzki, M; Räuber, S; Willison, A; Hartung, H-P; Melzer, N; König, S; Schweizer, M; Drexler, HCA; Stühler, K; Poschmann, G; Roos, A; Stenzel, W; Meisel, A; Meuth, SG; Ruck, T
Research article (journal) | Peer reviewedDetails about the publication
Journal: Acta Neuropathologica
Volume: 147
Article number: 102
Status: Published
Release year: 2024
Language in which the publication is written: English
Link to the full text: https://link.springer.com/article/10.1007/s00401-024-02754-6
Keywords: Myastenia gravis; proteomics; ITIH3
Authors from the University of Münster
| König, Simone | Interdisciplinary Centre for Clinical Research (IZKF) |